Literature DB >> 19954299

Increased expression of TLR7 in CD8(+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection.

Yang Song1, Yan Zhuang, Song Zhai, Dedong Huang, Ying Zhang, Wenzhen Kang, Xinhong Li, Qingquan Liu, Qigui Yu, Yongtao Sun.   

Abstract

It has recently been demonstrated that toll-like receptors (TLRs) can recognize structural conserved motifs carried by circulating microbial products and lead to systemic immune responses in individuals infected with HIV-1. TLRs have been detected in CD8(+) T cells at either a protein or RNA level. The role of TLRs on CD8(+) T cells involved in the host's immune responses during HIV-1 infection has not been well characterized. In this study, we analyzed expression of TLR4, TLR5, TLR7, and TLR8 in CD8(+) T cells in HIV-1 infection. All these four TLRs could be detected in CD8(+) T cells, but only TLR7 in CD8(+) T cells from HIV-1-infected individuals showed a higher expression level compared with that from healthy individuals (p < 0.05). The function of TLR7 in CD8(+) T cells was then investigated. We found that TLR7 ligand responsiveness significantly increased the expression of immune activation markers on purified CD8(+) T cells in HIV-1-infected individuals compared with healthy controls. And the levels of these markers were equivalent to those achieved by CD8(+) T cells from peripheral blood mononuclear cells (PBMCs). However, we also observed that TLR7 ligand stimulated significant IFN-gamma production by CD8(+) T cells in an accessory cell-dependent manner. Therefore, although CD8(+) T cells can be directly activated by TLR7, accessory cells must play an essential role in the activation of effective functions such as IFN-gamma production. These findings suggest that the abnormal expression of TLR7 in CD8(+) T cells from HIV-1-infected individuals may contribute to the abnormal immune activation in HIV-1 infection and play an important role in HIV-1 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19954299     DOI: 10.1089/aid.2008.0303

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

1.  Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection.

Authors:  Kevin B Walsh; John R Teijaro; Elina I Zuniga; Megan J Welch; Daniel M Fremgen; Shawn D Blackburn; Karl F von Tiehl; E John Wherry; Richard A Flavell; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2012-06-14       Impact factor: 21.023

2.  Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.

Authors:  Maarten Buitendijk; Susan K Eszterhas; Alexandra L Howell
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-05       Impact factor: 2.205

Review 3.  Toll-Like Receptor 7-Targeted Therapy in Respiratory Disease.

Authors:  Katie M Lebold; David B Jacoby; Matthew G Drake
Journal:  Transfus Med Hemother       Date:  2016-03-22       Impact factor: 3.747

4.  Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.

Authors:  Andrea Paun; Rashmi Bankoti; Trupti Joshi; Paula M Pitha; Simona Stäger
Journal:  PLoS Pathog       Date:  2011-01-06       Impact factor: 6.823

5.  R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes.

Authors:  Hua Nian; Wen-Qing Geng; Hua-Lu Cui; Ming-jia Bao; Zi-ning Zhang; Min Zhang; Ying Pan; Qing-Hai Hu; Hong Shang
Journal:  BMC Infect Dis       Date:  2012-01-14       Impact factor: 3.090

6.  Direct Toll-Like Receptor 8 signaling increases the functional avidity of human CD8+ T lymphocytes generated for adoptive T cell therapy strategies.

Authors:  Jean-François Chatillon; Mohamad Hamieh; Florence Bayeux; Claire Abasq; Emilie Fauquembergue; Aurélie Drouet; Florian Guisier; Jean-Baptiste Latouche; Philippe Musette
Journal:  Immun Inflamm Dis       Date:  2015-02-19

7.  An ENU-induced splicing mutation reveals a role for Unc93b1 in early immune cell activation following influenza A H1N1 infection.

Authors:  E I Lafferty; A Flaczyk; I Angers; R Homer; E d'Hennezel; D Malo; C A Piccirillo; S M Vidal; S T Qureshi
Journal:  Genes Immun       Date:  2014-05-22       Impact factor: 2.676

8.  TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells.

Authors:  Rujuta A Bam; Derek Hansen; Alivelu Irrinki; Andrew Mulato; Gregg S Jones; Joseph Hesselgesser; Christian R Frey; Tomas Cihlar; Stephen R Yant
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

9.  Toll-Like Receptor 7 Activation Enhances CD8+ T Cell Effector Functions by Promoting Cellular Glycolysis.

Authors:  Qian Li; Yan Yan; Jia Liu; Xuan Huang; Xiaoyong Zhang; Carsten Kirschning; Haifeng C Xu; Philipp A Lang; Ulf Dittmer; Ejuan Zhang; Mengji Lu
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

10.  The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.

Authors:  Mathieu F Chevalier; Gaël Petitjean; Catherine Dunyach-Rémy; Céline Didier; Pierre-Marie Girard; Maria Elena Manea; Pauline Campa; Laurence Meyer; Christine Rouzioux; Jean-Philippe Lavigne; Françoise Barré-Sinoussi; Daniel Scott-Algara; Laurence Weiss
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.